{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:55:48Z","timestamp":1760144148895,"version":"build-2065373602"},"reference-count":28,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Factor VII (FVII) deficiency is a rare bleeding disorder that can be classified as congenital or acquired, and the majority of acquired cases are due to vitamin K deficiency or liver disease. Isolated acquired FVII deficiency is a rare occurrence and has been associated with inhibitors or auto-antibodies. Here, we describe a patient with polycythemia vera who developed systemic mastocytosis and FVII deficiency simultaneously. FVII deficiency was not caused by inhibitors and improved with antineoplastic treatment. Acquired FVII deficiency has been reported in cases of sepsis, possibly due to proteolytic degradation induced by the activation of monocytes or endothelial cells. Malignancies have been shown to cause a depletion in circulating FVII through the direct binding of cancer cells. This case report suggests a potential association between SM associated with a hematological neoplasm (SM-AHN) and acquired FVII deficiency. Further evaluations are recommended in patients with systemic mastocytosis to gain a better understanding of the relationship between pathological mast cells and clotting factor concentrations.<\/jats:p>","DOI":"10.3390\/hematolrep16010014","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T12:17:16Z","timestamp":1710245836000},"page":"132-139","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factor VII Deficiency in Systemic Mastocytosis with an Associated Myeloid Neoplasm"],"prefix":"10.3390","volume":"16","author":[{"given":"Giorgio","family":"Rosati","sequence":"first","affiliation":[{"name":"Department of Clinical and Biological Sciences, San Luigi Gonzaga Hospital, University of Turin, 10043 Orbassano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0388-955X","authenticated-orcid":false,"given":"Sofia","family":"Camerlo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, San Luigi Gonzaga Hospital, University of Turin, 10043 Orbassano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Fornari","sequence":"additional","affiliation":[{"name":"Department of Oncology, Division of Pathology, San Luigi Gonzaga Hospital, 10043 Orbassano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Marci","sequence":"additional","affiliation":[{"name":"Department of Oncology, Division of Pathology, San Luigi Gonzaga Hospital, 10043 Orbassano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5713-2069","authenticated-orcid":false,"given":"Barbara","family":"Montaruli","sequence":"additional","affiliation":[{"name":"Laboratory Analyses, Azienda Ospedaliera Ordine Mauriziano, 10128 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8407-2903","authenticated-orcid":false,"given":"Alessandro","family":"Morotti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, San Luigi Gonzaga Hospital, University of Turin, 10043 Orbassano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1046\/j.1365-2141.2002.03545.x","article-title":"Factor Vii Deficiency","volume":"118","author":"Perry","year":"2002","journal-title":"Br. J. Haematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/1076029616670257","article-title":"Factor VII Deficiency: From Basics to Clinical Laboratory Diagnosis and Patient Management","volume":"23","author":"Sevenet","year":"2017","journal-title":"Clin. Appl. Thromb."},{"key":"ref_3","first-page":"63","article-title":"Isolated acquired factor VII deficiency: Review of the literature","volume":"71","author":"Mulliez","year":"2016","journal-title":"Acta Clin. Belg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/1076029615599440","article-title":"Acquired Isolated FVII Deficiency: An Underestimated and Potentially Important Laboratory Finding","volume":"22","author":"Girolami","year":"2016","journal-title":"Clin. Appl. Thromb."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/ajh.26962","article-title":"Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management","volume":"98","author":"Pardanani","year":"2023","journal-title":"Am. J. Hematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"ref_8","unstructured":"Clinical and Laboratory Standards Institute (2020). Determination of Coagulation Factor Activities Using the One-Stage Clotting Assay, CLSI Guidel H48, Clinical and Laboratory Standards Institute. [2nd ed.]."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3324\/haematol.2019.230771","article-title":"International recommendations on the diagnosis treatment of acquired hemophilia A","volume":"105","author":"Tiede","year":"2020","journal-title":"Haematologica"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3324\/haematol.2020.255117","article-title":"Acquired von Willebrand syndrome: Focused for hematologists","volume":"105","author":"Franchini","year":"2020","journal-title":"Haematologica"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2004-02-0595","article-title":"Recessively inherited coagulation disorders","volume":"104","author":"Mannucci","year":"2004","journal-title":"Blood"},{"key":"ref_12","first-page":"51","article-title":"Acquired isolated factor VII deficiency during sepsis","volume":"27","author":"Biron","year":"1997","journal-title":"Haemostasis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/0036933019853167","article-title":"Acquired Factor VII deficiency\u2014A rare but important consideration","volume":"64","author":"Zaidi","year":"2019","journal-title":"Scott. Med. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.annfar.2005.05.019","article-title":"Isolated acquired factor VII deficiency in patient with severe head trauma: Use of factor VII (factor VII-LFB)","volume":"24","author":"Meaudre","year":"2005","journal-title":"Ann. Fran\u00e7aises Anesth Reanim."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bmt.1703381","article-title":"Acquired factor VII deficiency in hematopoietic stem cell transplant recipients","volume":"29","author":"Toor","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/00001721-199410000-00023","article-title":"Acquired factor VII deficiency associated with pleural liposarcoma","volume":"5","author":"Dumont","year":"1994","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/pbc.21900","article-title":"Acquired factor VII deficiency associated with Wilms tumor","volume":"52","author":"Granger","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.athoracsur.2010.06.120","article-title":"Imaging and intervention of paraneoplastic effect of a right atrial myxoma on factor VII activity levels","volume":"91","author":"Fatimi","year":"2011","journal-title":"Ann. Thorac. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MBC.0000000000000024","article-title":"Acquired factor VII deficiency associated with acute myeloid leukemia","volume":"26","author":"Anoun","year":"2015","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1093\/labmed\/lmab120","article-title":"Acquired FVII Deficiency and Acute Myeloid Leukemia: A Case Report and Literature Review","volume":"53","author":"Hammami","year":"2022","journal-title":"Lab. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e932704-1","DOI":"10.12659\/AJCR.932704","article-title":"A Rare Case of Factor VII Inhibitor in a Patient Presenting with Primary Splenic Marginal Zone Lymphoma","volume":"22","author":"Naismith","year":"2021","journal-title":"Am. J. Case Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/jha2.482","article-title":"Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case report","volume":"3","author":"Goyal","year":"2022","journal-title":"eJHaem"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e1414","DOI":"10.1097\/MD.0000000000001414","article-title":"A French National Survey on Clotting Disorders in Mastocytosis","volume":"94","author":"Carvalhosa","year":"2015","journal-title":"Medicine"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Seidel, H., Hertfelder, H.J., Oldenburg, J., Kruppenbacher, J.P., Afrin, L.B., and Molderings, G.J. (2021). Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168960"},{"key":"ref_25","first-page":"491","article-title":"Acquired von Willebrand syndrome during systemic mastocytosis: An analysis of 21 cases","volume":"128","author":"Mital","year":"2018","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1160\/TH11-05-0351","article-title":"Bleeding diathesis in patients with mast cell activation disease","volume":"106","author":"Seidel","year":"2011","journal-title":"Thromb. Haemost."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/1076029607309173","article-title":"Fatal Bleeding Due to a Heparin-Like Anticoagulant in a 37-Year-Old Woman Suffering From Systemic Mastocytosis","volume":"14","author":"Sucker","year":"2008","journal-title":"Clin. Appl. Thromb."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1757-1626-1-100","article-title":"An unusual cause of spontaneous bleeding in the intensive care unit\u2014Mastocytosis: A case report","volume":"1","author":"Koenig","year":"2008","journal-title":"Cases J."}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/16\/1\/14\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:12:16Z","timestamp":1760105536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/16\/1\/14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["hematolrep16010014"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep16010014","relation":{},"ISSN":["2038-8330"],"issn-type":[{"type":"electronic","value":"2038-8330"}],"subject":[],"published":{"date-parts":[[2024,3,12]]}}}